Congratulations to Abier Hamidi on the acceptance of her Ph.D. paper ‘Facilitators and barriers to condom use in Middle East and North Africa: a systematic review’. [1] This review has been registered on PROSPERO. [2] The Journal of Public Health is part of BU’s publishing deal with Springer, hence it will free open access when published.
Abier is supervised by Dr. Pramod Regmi, Senior Lecturer in International Health and the Global Engagement Lead in the Department of Nursing Sciences, and Prof. Edwin van Teijlingen in the Centre for Midwifery, Maternal & Perinatal Health (CMMPH). Earlier Abier published ‘HIV epidemic in Libya: Identifying gaps’ in 2021. [3]
References:
- Hamidi, A., Regmi, P., van Teijlingen, E. (2023) Facilitators and barriers to condom use in Middle East and North Africa: a systematic review, Journal of Public Health, (accepted)
- Hamidi, A., van Teijlingen, E., Regmi, P. (2021) Facilitators and barriers to condom use in Middle East and North Africa: a systematic review. PROSPERO CRD42021297160
- Hamidi, A., Regmi, P., van Teijlingen, E. (2021) HIV epidemic in Libya: Identifying gaps, Journal of the International Association of Providers of AIDS Care, 20 :1-5 https://doi.org/10.1177/23259582211053964 .
Congratulations to FHSS PhD student Abier Hamidi
Two scholarships in one month for PhD student
Congratulations to PhD student Raksha Thapa
New COVID-19 publication by FHSS academics










Fourth INRC Symposium: From Clinical Applications to Neuro-Inspired Computation
ESRC Festival of Social Science 2025 – Reflecting back and looking ahead to 2026
3C Event: Research Culture, Community & Cookies – Tuesday 13 January 10-11am
Dr. Chloe Casey on Sky News
Final Bournemouth University publication of 2025
ECR Funding Open Call: Research Culture & Community Grant – Application Deadline Friday 12 December
MSCA Postdoctoral Fellowships 2025 Call
ERC Advanced Grant 2025 Webinar
Horizon Europe Work Programme 2025 Published
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease